WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
NWS: Tuesday Hail Storm will be Remembered as Major Weather Event
Stone County Traffic Crash Involves Drivers from Arkansas, Missouri
Branson West Man Faces Federal Money Laundering Charges
Silver Dollar City Earns Top USA Today Award for Fifth Time
Final Day of Storms Sees Hail Pelt the Ozarks